| Centers for Disease Control (CDC)
|
Strengthening Public Health Systems & Services through National Partnerships to Improve & Protect the Nation's Health
|
$3,000,000 |
3/20/2020
(anticipated)
|
|
Applied Research Address the Coronavirus (COVID-19) Emerging Public Health Emergency
|
|
3/25/2020
(call for white papers) |
|
Department of Defense (DoD)
|
Request for Information for PPE in response to COVID-19
|
N/A |
3/24/2020
(information accepted on a rolling basis) |
|
Prototype Development to Combat Novel Coronavirus Disease COVID-19
|
TBD |
4/15/2020 |
| Department of Energy (DOE) |
Soliciting input to COVID-19 response
|
DOE Resources |
Rolling |
| Medical CBRN Defense Consortium (MCDC)
|
Prototype Development to Combat Coronavirus (COVID-19)
|
undetermined |
pre-announcement |
|
RFI CoV Pandemic Response
|
undetermined |
3/19/2020-5/21/2020
(call for rapid response white papers)
|
| Leveraging STRIDES for Cloud Computing Activities in Common Fund Awards (NOT-RM-20-009) |
Cloud Computing support >$10,000 |
beginning 4/1/2020 |
| National Institutes of Health |
Administrative Supplement NIAID |
no limit |
2/6/2020
(applications accepted through 2/6/2021) |
| NOSI Regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025) |
not greater than parent award and reflective of actual need |
3/5/2020
(applications accepted through 2/5/2021) |
| Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21) (PAR-18-781) |
$275,000 |
9/9/2020 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047) |
no limit |
3/19/2020-3/31/2020 |
| Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCOV)(NOT-AI-20-30) |
No limit |
2/6/2021
(rolling basis) |
| NOSI: Availability of Administrative Supplements & Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757) |
not specified |
3/17/2020 - 10/5/2020
(rolling basis) |
| Administrative Supplements to existing NIH Grants & Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
No limit |
Differs - check with Institutes/Centers |
| Partnerships for Countermeasures Against Select Pathogens (R01 Clinical Trials not Allowed) |
$3,750,000 |
6/29/2020 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
No limit |
5/13/2020, 9/13/2020, see RFA for additional deadlines |
| National Science Foundation (NSF) |
RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) |
$200,000 |
check with program officers for eligibility |
| Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) |
$200,000 (RAPID) & supplemental funding requests |
check with program officers for eligibility |
| Office of Management & Budget (OMB) |
Administrative Relief for Recipients & Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (M-20-17) |
unspecified |
effective immediately |
| Biomedical Advanced Research & Development Authority (BARDA) |
BARDA Broad Agency Announcement |
negotiated after white paper submission |
10/31/2020 |
| White House Office of Science & Technology |
COVID-19 High Performance Computing Consortium (Xsede) |
Computing Resources |
effective immediately |
